192 related articles for article (PubMed ID: 22583042)
1. The prevalence of endometrial hyperplasia and endometrial cancer in women with polycystic ovary syndrome or hyperandrogenism.
Holm NS; Glintborg D; Andersen MS; Schledermann D; Ravn P
Acta Obstet Gynecol Scand; 2012 Oct; 91(10):1173-6. PubMed ID: 22583042
[TBL] [Abstract][Full Text] [Related]
2. The insulin-resistant phenotype of polycystic ovary syndrome.
Svendsen PF; Madsbad S; Nilas L
Fertil Steril; 2010 Aug; 94(3):1052-8. PubMed ID: 19580964
[TBL] [Abstract][Full Text] [Related]
3. A simple screening approach for assessing community prevalence and phenotype of polycystic ovary syndrome in a semi-urban population in Sri Lanka.
Kumarapeli V; Seneviratne Rde A; Wijeyaratne CN; Yapa RM; Dodampahala SH
Am J Epidemiol; 2008 Aug; 168(3):321-8. PubMed ID: 18550559
[TBL] [Abstract][Full Text] [Related]
4. Polycystic ovary syndrome and risk of endometrial cancer: a mini-review.
Tokmak A; Kokanali MK; Guzel AI; Kara A; Topcu HO; Cavkaytar S
Asian Pac J Cancer Prev; 2014; 15(17):7011-4. PubMed ID: 25227783
[TBL] [Abstract][Full Text] [Related]
5. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
Hassa H; Tanir HM; Yildiz Z
Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
[TBL] [Abstract][Full Text] [Related]
6. The percentages of endometrial hyperplasia and endometrial cancer among polycystic ovary syndrome (PCOS) patients presenting with abnormal menstrual pattern.
Prakansamut N; Sirayapiwat P; Triratanachat S
J Med Assoc Thai; 2014 Feb; 97(2):159-64. PubMed ID: 24765893
[TBL] [Abstract][Full Text] [Related]
7. Clinical presentation and etiologic factors of hirsutism in premenopausal Iranian women.
Ansarin H; Aziz-Jalali MH; Rasi A; Soltani-Arabshahi R
Arch Iran Med; 2007 Jan; 10(1):7-13. PubMed ID: 17198446
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of endometrial cancer and hyperplasia in non-symptomatic overweight and obese women.
Viola AS; Gouveia D; Andrade L; Aldrighi JM; Viola CF; Bahamondes L
Aust N Z J Obstet Gynaecol; 2008 Apr; 48(2):207-13. PubMed ID: 18366497
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of polycystic ovarian syndrome in Indian adolescents.
Nidhi R; Padmalatha V; Nagarathna R; Amritanshu R
J Pediatr Adolesc Gynecol; 2011 Aug; 24(4):223-7. PubMed ID: 21600812
[TBL] [Abstract][Full Text] [Related]
10. [Exploration of the classification of polycystic ovarian syndrome].
Lin JF; Li X; Zhu MW
Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
[TBL] [Abstract][Full Text] [Related]
11. Endometrial thickness predicts endometrial hyperplasia in patients with polycystic ovary syndrome.
McCormick BA; Wilburn RD; Thomas MA; Williams DB; Maxwell R; Aubuchon M
Fertil Steril; 2011 Jun; 95(8):2625-7. PubMed ID: 21550041
[TBL] [Abstract][Full Text] [Related]
12. Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism.
Ozdemir S; Ozdemir M; Görkemli H; Kiyici A; Bodur S
Acta Obstet Gynecol Scand; 2010; 89(2):199-204. PubMed ID: 19900078
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of polycystic ovary syndrome in women seeking treatment from community electrologists. Alabama Professional Electrology Association Study Group.
Farah L; Lazenby AJ; Boots LR; Azziz R
J Reprod Med; 1999 Oct; 44(10):870-4. PubMed ID: 10554748
[TBL] [Abstract][Full Text] [Related]
14. The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome.
Amato MC; Galluzzo A; Finocchiaro S; Criscimanna A; Giordano C
Clin Endocrinol (Oxf); 2008 Jul; 69(1):52-60. PubMed ID: 18034780
[TBL] [Abstract][Full Text] [Related]
15. The investigation and management of severe hyperandrogenism pre- and postmenopause: non-tumor disease is strongly associated with metabolic syndrome and typically responds to insulin-sensitization with metformin.
Vaikkakara S; Al-Ozairi E; Lim E; Advani A; Ball SG; James RA; Quinton R
Gynecol Endocrinol; 2008 Feb; 24(2):87-92. PubMed ID: 18210332
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for young premenopausal women with endometrial cancer.
Soliman PT; Oh JC; Schmeler KM; Sun CC; Slomovitz BM; Gershenson DM; Burke TW; Lu KH
Obstet Gynecol; 2005 Mar; 105(3):575-80. PubMed ID: 15738027
[TBL] [Abstract][Full Text] [Related]
17. Ovarian morphology and prevalence of polycystic ovary syndrome in reproductive aged women with or without mild acne.
Kelekci KH; Kelekci S; Incki K; Ozdemir O; Yilmaz B
Int J Dermatol; 2010 Jul; 49(7):775-9. PubMed ID: 20618496
[TBL] [Abstract][Full Text] [Related]
18. Anovulation with or without PCO, hyperandrogenaemia and hyperinsulinaemia as promoters of endometrial and breast cancer.
Papaioannou S; Tzafettas J
Best Pract Res Clin Obstet Gynaecol; 2010 Feb; 24(1):19-27. PubMed ID: 19264556
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women.
Alvarez-Blasco F; Botella-Carretero JI; San Millán JL; Escobar-Morreale HF
Arch Intern Med; 2006 Oct; 166(19):2081-6. PubMed ID: 17060537
[TBL] [Abstract][Full Text] [Related]
20. Non polycystic ovary syndrome-related endocrine disorders associated with hirsutism.
Unluhizarci K; Kaltsas G; Kelestimur F
Eur J Clin Invest; 2012 Jan; 42(1):86-94. PubMed ID: 21623779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
